Femasys stock.

Find the latest Femasys Inc. (FEMY) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Nov. 30, 2023 5:40 PM ET Femasys Inc. (FEMY) By: Tiyashi Datta, SA News Editor. Femasys ( NASDAQ: FEMY) filed a prospectus related to the offer and resale by the selling stockholders of up to an ...An Atlanta woman-founded, women's healthcare company plans to raise $40 million in an initial public stock offering. Suwanee-based Femasys Inc. says in plans filed May 14 with the Securities and ...Femasys ( NASDAQ: FEMY) shares jumped 21% midday Monday following news that the US Food and Drug Administration has approved its investigational device exemption application to begin clinical ...

View Our Latest Stock Analysis on FEMY. Femasys Price Performance. FEMY opened at $0.96 on Monday. The business has a fifty day moving average of $1.25 and a 200 day moving average of $0.81. Femasys has a 52-week low of $0.25 and a 52-week high of $4.75. The company has a quick ratio of 8.28, a current ratio of 4.68 and a …PR Newswire — Thinking about buying stock in Ardelyx, Rivian Automotive, Femasys, Lucid Group, or Outlook Therapeutics? News • Oct 11, 2023 Morningstar — Femasys Inc. Regains Compliance with Nasdaq Listing Requirements

Overview. Femasys Inc. is a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health.- FemaSeed ® is the first-ever, first-line approach designed to deliver sperm directly where conception occurs -. ATLANTA, April 18, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs by developing a suite of products and product candidates that include minimally invasive, in …

Femasys Inc. Common Stock (FEMY) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Gainers Femasys Inc. (NASDAQ: FEMY) shares rose 201% to $1.00 in pre-market trading after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment.Share this article. Femasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical Officer -- Thought leader from top-ranked academic gynecology …WebOverview. Femasys Inc. is a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health.Nov 24, 2023 · Complete Femasys Inc. stock information by Barron's. View real-time FEMY stock price and news, along with industry-best analysis.

Under the terms of the investment, the investors were also issued two series of warrants: warrants to purchase approximately 5.8 million shares of common stock at an exercise price of $1.18 per ...

FemBloc® patent application provides additional coverage for Femasys’ therapeutic option for women seeking permanent birth controlATLANTA, July 27, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ ...

Nov 30, 2023 · According to 3 stock analysts, the average 12-month stock price forecast for Femasys stock is $9.00, which predicts an increase of 845.18%. The lowest target is $7.00 and the highest is $10. On average, analysts rate Femasys stock as a strong buy. Femasys : FEMY got FDA ... This revolutionary clearance has primed ICU for an explosion, and accordingly, analysts label the stock as a Buy with an average target price of $1.00. That represents a ...Femasys (FEMY) For the next stock on our list, we’ll take a look at another company in the health care universe. Femasys occupies a unique niche, whose nature is implied in the name.Femasys-stock Femasys Inc Registered Shs Stock , FEMY 0.95 -0.01 -1.53% After-market 07:34:36 PM EDT 11/17/2023 NAS Add to watchlist 0.96 +0.04 …WebView live Femasys Inc. chart to track its stock's price action. Find market predictions, FEMY financials and market news. ... Femasys, Inc. is a biomedical company, which engages in the development of novel solutions for reproductive healthcare.

Find the latest SEC Filings data for Femasys Inc. Common Stock (FEMY) at Nasdaq.com.Find the latest Femasys Inc. (FEMY) stock quote, history, news and other vital information to help you with your stock trading and investing.The stock is up ~205% in after-hours trading on Monday. Femasys (FEMY) says that FeedSeed is "less invasive and more affordable than assisted reproduction procedures, such as in vitro ...Electronic Technology. Industry. Electronic Equipment/Instruments. No executives to display. Corporate headquarters. --, --. Find real-time FEMY - Femasys Inc stock quotes, company profile, news ...26 sept 2023 ... Femasys investors are celebrating on Tuesday after the company got approval from for its infertility treatment. This has FEMY stock rising.

12 Health Care Stocks Moving In Wednesday's After-Market Session. Gainers telesis bio (nasdaq:tbio) shares increased by 32.5% to $0.53 during wednesday's after-market session. Femasys shares rose 19.28% and axcella health shares rose 13.1%. Gyre therapeutics stock decreased by 8.67% and impel pharmaceuticals declined by 13.3%.Find real-time FEMY - Femasys Inc stock quotes, company profile, news and forecasts from CNN Business.

Electronic Technology. Industry. Electronic Equipment/Instruments. No executives to display. Corporate headquarters. --, --. Find real-time FEMY - Femasys Inc stock quotes, company profile, news ...Femasys’ FemBloc ® permanent birth control in late-stage clinical development is the first and only non-surgical, in-office, permanent birth control method intended to be a safer option for ...When picking the best stocks under $10 to buy, it's important to identify fundamentally strong and non-speculative stocks. These are fundamentally strong and non-speculative stocks that are under $10 Since the meme stock euphoria in 2020, i...Femasys Inc ( FEMY) has fallen Tuesday morning, with the stock losing -1.54% in pre-market trading to 1.28. FEMY's short-term technical score of 47 indicates that the stock has traded less bullishly over the last month than 53% of stocks on the market. In the Medical Instruments & Supplies industry, which ranks 80 out of 146 industries, Femasys ...Ratings analysis incomplete due to data availability. Recommendations not provided. Maximize Income Goal. See Best High Dividend Stocks Model Portfolio for our ...At Femasys Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.Femasys Inc. (FEMY) delivered earnings and revenue surprises of -8.70% and 13.25%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?Femasys has an analyst consensus of Strong Buy, with a price target consensus of $7.33, representing a 543.0% upside. In a report issued on September 26, JonesTrading also maintained a Buy rating ...H.C. Wainwright analyst Emily Bodnar maintained a Buy rating on Femasys (FEMY – Research Report) today and set a price target of $5.00.The company’s shares opened today at $0.82. According to ...NASDAQ:FEMY - Femasys Stock Price, News & Analysis Femasys Stock Price, News & Analysis (NASDAQ:FEMY) $0.98 -0.03 (-2.98%) (As of 11/29/2023 ET) …Web

That’s a massive surge in trading volume compared to Femasys’ daily average of about 3.3 million shares. FEMY stock is up 180.9% as of Tuesday morning after closing out Monday down 63.2% year ...

Detailed statistics for Femasys Inc. (FEMY) stock, including valuation metrics, financial numbers, share information and more. Detailed statistics for Femasys Inc. (FEMY) ... The stock price has decreased by -20.16% in the last 52 weeks. The beta is -3.54, so Femasys's price volatility has been lower than the market average. Beta (1Y)

Dec 1, 2023 · Femasys Inc FEMY Morningstar Rating Unlock Stock XNAS Rating as of Nov 24, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating Performance... At Femasys Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.Shares of biomedical firm Femasys soared on Thursday.; Management announced the issuance of a notice of allowance for its patent application. FEMY stock soared on IP protection of its first-of-its ...Ratings analysis incomplete due to data availability. Recommendations not provided. Maximize Income Goal. See Best High Dividend Stocks Model Portfolio for our ...Femasys Inc ( FEMY) has fallen Tuesday morning, with the stock losing -1.54% in pre-market trading to 1.28. FEMY's short-term technical score of 47 indicates that the stock has traded less bullishly over the last month than 53% of stocks on the market. In the Medical Instruments & Supplies industry, which ranks 80 out of 146 industries, …Femasys stock has received a consensus rating of buy. The average rating score is and is based on 12 buy ratings, 0 hold ratings, and 0 sell ratings. What was the 52-week low for Femasys stock?Portfolio Overview. Our non-surgical, proprietary delivery platform requires no capital equipment and leverages existing intrauterine techniques. Our minimally invasive technologies are designed to provide safe, convenient in-office approaches, saving time and reducing costs. Femasys has an expansive, internally-created intellectual property ...Track Femasys Inc (FEMY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsSince then, however, the stock has slipped by 47%. Writing on Femasys for Chardan Research, 5-star analyst Keay Nakae takes care to laud “the potential of its next generation products addressing ...Femasys Inc.is a biomedical company focused on transforming women's healthcare by developing novel solutions as well as providing significant clinical impact to address severely underserved areas. The company's lead product candidates offer FemBloc and FemaSeed. Femasys Inc. is based in ATLANTA. Stock split history for Femasys since 2021.FEMY Stock 12 Months Forecast. Based on 4 Wall Street analysts offering 12 month price targets for Femasys in the last 3 months. The average price target is $10.67 with a high forecast of $13.00 and a low forecast of $7.00. The average price target represents a 620.95% change from the last price of $1.48.Portfolio Overview. Our non-surgical, proprietary delivery platform requires no capital equipment and leverages existing intrauterine techniques. Our minimally invasive technologies are designed to provide safe, convenient in-office approaches, saving time and reducing costs. Femasys has an expansive, internally-created intellectual property ...

Publish : 04 Oct 2023, 07:17 PM Update : 04 Oct 2023, 07:17 PM. Femasys (NASDAQ: FEMY) stock is down 50% over night from highs. A reasonable bet would be that FEMY stock will continue to fall back to more reasonable levels. For, as far as we can see at least, this is a flurry of speculation producing far too much movement for the objective ...12 Health Care Stocks Moving In Wednesday's After-Market Session. Gainers telesis bio (nasdaq:tbio) shares increased by 32.5% to $0.53 during wednesday's after-market session. Femasys shares rose 19.28% and axcella health shares rose 13.1%. Gyre therapeutics stock decreased by 8.67% and impel pharmaceuticals declined by 13.3%.Operating Status Active. Last Funding Type Post-IPO Debt. Legal Name Femasys Inc. Stock Symbol NASDAQ:FEMY. Company Type For Profit. Contact Email [email protected]. Phone Number 1 (770) 500-3910. Femasys is a biomedical company focused on transforming women’s healthcare worldwide by …Instagram:https://instagram. pave pricedoes chipotle have nachoscargvfmv That’s a massive surge in trading volume compared to Femasys’ daily average of about 3.3 million shares. FEMY stock is up 180.9% as of Tuesday morning after closing out Monday down 63.2% year ...Currently, the analyst consensus on Femasys is a Strong Buy with an average price target of $6.67. See today’s best-performing stocks on TipRanks >> Trevena (TRVN) rv giveaway 2023xle stock quote About Femasys. Femasys is a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead ...Femasys: Other Events, Financial Statements And Exhibits. November 28, 2023 U.S. Securities and Exchange Commission. Item 8.01 Other Events On November 28, 2023, Femasys Inc. (the “Company”) announced the completion of enrollment in pivotal trial of its intratubal insemination product FemaSeed. A copy of the press release is being … ram stock 55.59%. Dividend Yield. 3.98%. Kenvue's products fall into three segments: self care like Tylenol pain reliever, skin health and beauty such as Neutrogena lotions, and essential health like Band ...PharmaCyte Biotech makes $5M investment in Femasys to utilize cash position. The Fly 12 days ago. Track Femasys Inc (FEMY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.